Skip to main content

Day: July 30, 2020

Verkkokauppa.com Oyj – Johdon liiketoimet – Seppälä

Verkkokauppa.com Oyj             JOHDON LIIKETOIMET              30.7.2020 klo 15.00Verkkokauppa.com Oyj – Johdon liiketoimet – SeppäläMarkkinoiden väärinkäyttöasetuksen 19. artiklan mukainen ilmoitus liiketoimesta.IlmoitusvelvollinenNimi: Seppälä, SamuliAsema: Hallituksen jäsen____________________________________________Liikkeeseenlaskija: Verkkokauppa.com OyjLEI: 743700QZE6B52SHHTV75Ilmoituksen luonne: ENSIMMÄINEN ILMOITUSViitenumero: 743700QZE6B52SHHTV75_20200728234228_3____________________________________________Liiketoimen päivämäärä: 2020-07-27Instrumenttityyppi: OSAKEISIN: FI4000049812Liiketoimen luonne: LUOVUTUSLiiketoimien yksityiskohtaiset tiedotLiiketoimien yhdistetyt tiedot(93): Volyymi: 96 076 Keskihinta: 5,5935 EUR ____________________________________________Liiketoimen päivämäärä: 2020-07-28Instrumenttityyppi: OSAKEISIN:...

Continue reading

Williams Industrial Services Group Schedules Second Quarter 2020 Financial Results Conference Call

ATLANTA, July 30, 2020 (GLOBE NEWSWIRE) — Williams Industrial Services Group Inc. (OTCQX: WLMS), a construction and maintenance services company, will release financial results for second quarter ended June 30, 2020 after the close of financial markets on August 13, 2020. Management will host a conference call and webcast the following morning to discuss the results; a question-and-answer session will follow.Second Quarter 2020 Conference Call                August 14, 202010:00 a.m. Eastern TimePhone: (201) 493-6780Internet webcast link and accompanying slide presentation: http://ir.wisgrp.com/ An audio replay of the earnings call will be available later that day by dialing 412-317-6671 and entering conference ID number 13706819. Alternatively, the webcast replay can be accessed at http://ir.wisgrp.com/.About Williams Industrial...

Continue reading

Juniper Networks Recognized as a Leader in Open, Programmable Switches for a Businesswide Software-Defined Networking Report

SUNNYVALE, Calif., July 30, 2020 (GLOBE NEWSWIRE) — Juniper Networks (NYSE:JNPR), a leader in secure, AI-driven networks, today announced it has been positioned as a Leader in The Forrester Wave™: Open, Programmable Switches For A Businesswide SDN, Q3 2020, a new report published by Forrester Research, Inc. This detailed external assessment follows Juniper also being named by Gartner as a Leader in the data center earlier this month.One of the Forrester report’s key takeaways identifies “single OS and extensible and programmable switching” as differentiators to building a businesswide SDN, which we consider to be a contrast to the inflexible solutions of many incumbents.According to the report, “Juniper Networks recognizes that customers need more than technology and products and has developed various resources to educate customers...

Continue reading

AETERNA ZENTARIS ANNOUNCES ABSTRACT OF RESULTS FROM FIRST PEDIATRIC STUDY OF MACIMORELIN ACCEPTED FOR PRESENTATION AT THE 22ND EUROPEAN CONGRESS OF ENDOCRINOLOGY

CHARLESTON, S.C., July 30, 2020 (GLOBE NEWSWIRE) — Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) ( the “Company”), a specialty biopharmaceutical company commercializing and developing therapeutics and diagnostic tests, today announced that the abstract on study results of its first pediatric study on macimorelin has been selected for presentation at the 22nd European Congress of Endocrinology (e-ECE 2020) being held September 5-9, 2020.The accepted abstract titled Pharmacokinetics and pharmacodynamics of macimorelin acetate (AEZS-130) in paediatric patients with suspected growth hormone deficiency (GHD), will be presented as an ePoster accommodated by an audio commentary during the event.Abstracts are under embargo until published in Endocrine Abstracts before the start of e-ECE 2020. Endocrine Abstracts is an entirely online,...

Continue reading

BetterLife Pharma Receives Approval from Altum Pharmaceuticals Inc. Shareholders to Complete Merger

Vancouver, July 30, 2020 (GLOBE NEWSWIRE) — BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT), an emerging biotechnology company with proprietary interferon-based therapeutic technologies, is pleased to provide an update on the results of the Special Meeting of the shareholders of Altum Pharmaceuticals Inc. (“Altum”) to approve the merger with BetterLife.On July 29, 2020, an overwhelming 91.3% of Altum shareholders voted in favour of the merger with BetterLife.  BetterLife now awaits ratification of the merger by the Canadian Securities Exchange.Mr. Robert Metcalfe, lead director of BetterLife, said, “We are very pleased with the results of the votes from the Altum shareholders and to receive more than 91% support in favor of the merger with BetterLife. We look forward to the completion...

Continue reading

Pacira to Report Second Quarter 2020 Financial Results on Thursday August 6, 2020

PARSIPPANY, N.J., July 30, 2020 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (NASDAQ:PCRX) today announced that it will report its second quarter financial results before the open of the U.S. markets on Thursday, August 6, 2020. Following the release, the company will host a live conference call and webcast at 8:30 a.m. ET.To participate in the conference call, dial 1-877-845-0779 and provide the passcode 3276818. International callers may dial 1-720-545-0035 and use the same passcode. In addition, a live audio of the conference call will be available as a webcast. Interested parties can access the event through the “Events” page on the Pacira website at investor.pacira.com.For those unable to participate in the live call, a replay will be available at 1-855-859-2056 (domestic) or 1-404-537-3406 (international) using the passcode...

Continue reading

Kura Oncology to Report Second Quarter 2020 Financial Results

SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) — Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for the treatment of cancer, today announced that it will report second quarter 2020 financial results after the close of U.S. financial markets on Thursday, August 6, 2020. Kura’s management will host a webcast and conference call at 4:30 p.m. ET / 1:30 p.m. PT that day to discuss the financial results and provide a corporate update.The live call may be accessed by dialing (866) 278-7953 for domestic callers and (323) 347-3281 for international callers and entering the conference code: 1697775. A live webcast and archive of the call will be available online from the investor relations section of the company website at www.kuraoncology.com.About Kura OncologyKura...

Continue reading

Hubbell Reports Second Quarter 2020 Results

Shelton, CT, July 30, 2020 (GLOBE NEWSWIRE) —HUBBELL REPORTS SECOND QUARTER 2020EARNINGS PER DILUTED SHARE OF $1.62 ANDADJUSTED EARNINGS PER DILUTED SHARE OF $1.87(1)Q2 net sales -21% (organic -21%)Q2 diluted EPS of $1.62; adjusted diluted EPS of $1.87(1)Includes restructuring and related investment ($0.09)Q2 Free Cash Flow of $178 million(3)Reinstating FY20 diluted EPS guidance of $6.00-$6.25; adjusted EPS of $7.00-$7.25(1)SHELTON, CT. (July 30, 2020) – Hubbell Incorporated (NYSE: HUBB) today reported operating results for the second quarter ended June 30, 2020.“Hubbell effectively navigated a challenging economic environment in the second quarter, delivering operating margin expansion and strong free cash flow generation despite significantly lower volumes,” said David G. Nord, Chairman and Chief Executive Officer. “We continue...

Continue reading

Intellia Therapeutics to Hold Conference Call to Discuss Second Quarter 2020 Earnings and Company Updates

CAMBRIDGE, Mass., July 30, 2020 (GLOBE NEWSWIRE) — Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading genome editing company focused on developing curative therapeutics using CRISPR/Cas9 technology both in vivo and ex vivo, will present its second quarter 2020 financial results and operational highlights in a conference call on August 6, 2020 at 8 a.m. ET.To join the call:U.S. callers should dial 1-877-317-6789 and international callers should dial +1-412-317-6789, approximately five minutes before the call.All participants should ask to be connected to the Intellia Therapeutics conference call.A replay of the call will be available through the Events and Presentations page of the Investors & Media section of the company’s website at www.intelliatx.com, beginning on August 6, 2020 at 12 p.m. ET.About Intellia TherapeuticsIntellia...

Continue reading

Aleafia Health Launches Same-Day, Direct-to-Door Medical Cannabis Delivery

TORONTO, July 30, 2020 (GLOBE NEWSWIRE) — Aleafia Health Inc.’s (TSX: AH, OTC: ALEAF) (“Aleafia Health” or the “Company”) AssureHome Delivery, the industry-leading direct-to-door medical cannabis service, has now launched same-day delivery. Previously, the service offered next-day delivery only. Highlights include:Medical cannabis orders received before noon on any business day will be shipped and delivered the same day.Available to patients in the Greater Toronto Area and surrounding communities, home to over nine million people.Offered exclusively to medical cannabis patients registered with the Company’s wholly owned subsidiary, Emblem Cannabis Corporation.Patients receive a shipment tracking number and phone call 15 minutes prior to the driver’s arrival.Further expansion planned to other major metropolitan areas including Calgary...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.